Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Health Canada has granted approval for KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in ...

Patient-reported outcomes from the OUTBACK trial highlight common, persistent sexual side effects that should be addressed following cervical cancer treatment.

Akeso's Cadonilimab Gets NMPA Approval For First-line Cervical Cancer Treatment June 04, 2025 — 09:49 pm EDT Written by RTTNews.com for RTTNews -> ...

Akeso's PD-1/CTLA-4 Bispecific Antibody Cadonilimab Approved for First-Line Treatment of Cervical Cancer in All-Comer Populations--Third Approved Indication for Cadonilimab Akeso's PD-1/CTLA-4 ...

Circulating tumor DNA (ctDNA) levels in patients with cervical cancer before and during treatment were prognostic of disease progression and survival in a post hoc analysis of the phase 3 CALLA ...

Exercise may significantly improve cancer outcomes, according to a groundbreaking study released this week in a major cancer journal.

MINNEAPOLIS — Fewer than half of women treated for high-grade cervical dysplasia subsequently received guidance-concordant surveillance, of whom one-third had an abnormal co-test result ...

Some benefits include mitigation of cardiac toxicity, peripheral neuropathy, cognitive impairment, and dyspnea. (HealthDay News) — Exercise mitigates adverse outcomes associated with cancer and ...

Dr. Nicholas Fabiano, University of Ottawa, is reshaping our understanding of mental health treatment through innovative research on exercise and depression. His personal journey following a ...

This video will describe how cervical radiculopathy can cause pain, numbness and tingling down a persons arm, hands or fingers. Treatment options for this condition are also discussed.